Sovran Advisors’s Galectin Therapeutics GALT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$395K Sell
188,972
-10,858
-5% -$22.7K 0.04% 351
2025
Q1
$276K Buy
199,830
+13,816
+7% +$19.1K 0.04% 389
2024
Q4
$214K Buy
+186,014
New +$214K 0.03% 396